DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Giannitsis E.
Rationale for testing the cardiovascular risk for patients with COX-2 inhibitors on the basis of biomarker NT-proBNP.
Clin Lab 2005;
51: 63-83
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.